AMC ENTERTAINMENT HOLDINGS, INC. vs McKesson Corporation — how do they compare? AMC ENTERTAINMENT HOLDINGS, INC. trades at $2.41 (market cap $2.14B), while McKesson Corporation trades at $899.6 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 49.1× AMC ENTERTAINMENT HOLDINGS, INC.'s market cap, and McKesson Corporation pays the higher dividend (0.42%). Which is the better fit depends on your goals.
| AMC | MCK | |
|---|---|---|
Market Cap | $2.14B | $105.14B |
Sector | Media | Health |
52-Week High | $3.15 | $995.69 |
52-Week Low | $0.95 | $659.01 |
Enterprise Value | $9.08B | $111.67B |
Dividend Yield | 0.11% | 0.42% |
Signals from Pluang's Aura AI — not financial advice
AMC trades at $2.42, down 6.56% today, yet maintains a bullish technical signal with strong recent earnings beats. The company reported record Q2 2026 revenue and EBITDA, driven by surging attendance and premium screen growth. However, negative net income and substantial debt of $4.01 billion highlight financial strain. Analyst consensus is a $3.00 price target with mixed ratings (32% Buy, 46% Hold).
The outlook hinges on sustained box office recovery and cash flow improvement, with management citing a potential cash-flow breakthrough. Key risks include high leverage, dependence on film slate success, and meme-stock volatility. Upside exists if operational momentum continues, but the negative equity position warrants caution.
No Aura AI signal available yet.
Trailing returns across standard periods
AMC Entertainment Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, provides theatrical exhibition, movie screening, food distribution, online ticket booking, and other related services. AMC Entertainment offers movie theaters worldwide.
Read more on AMC →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →